Monday, January 7, 2019

U.S. Supreme Court rejects Amgen over cholesterol medication patent fight

The U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to reinstate a jury verdict it won against rivals Regeneron Pharmaceuticals Incand Sanofi SAin patent dispute over cholesterol medication.


from Reuters: Health News https://reut.rs/2VCOEUz
via IFTTT

0 comments:

Post a Comment